TMPRSS2 and prostate cancer: In favor of the luminal origin is also the recent observation showing that androgen receptor mediates formation of the TMPRSS2-ERG fusion in human prostate cancer cells, thus suggesting that cancer initiating events may occur at the level of androgen receptor-positive luminal cells [105,541].